Workflows in the Age of AI Agents

Agent-based artificial intelligence is considered as the next leap in productivity. The logic is simple viz., assign a task to an agent and let it run. Yet the effectiveness of these systems depends far less on the sophistication of the code and far more on the clarity of the workflow they are given.

A workflow is the structured path through which work moves from start to finish. It defines the sequence of tasks, the hand-offs between people or systems, and the expected outcomes at each stage. Within this path, the process provides the backbone, setting out how each step should be performed, what standards apply, and how exceptions are to be managed. Without these foundations, the very data that agents rely on becomes unreliable. It is like attempting a Six Sigma project without stabilising the process first, because what you are measuring is so inconsistent that any optimisation is built on sand.

This is easy to see in practice. Consider a hospital admission workflow, which involves multiple departments, sensitive data, and critical timing. The journey begins with patient registration, where details are collected, a unique identity is created, and basic documentation such as identification or insurance papers is checked. The next vital step is financial clearance, either through insurance verification or collection of a deposit. If this is skipped or handled late, problems cascade downstream. Once financial clearance is complete, a medical assessment follows, triaging emergencies and routing others for physician review. Bed or room allocation then takes place, coordinated with housekeeping and transport to ensure readiness. Finally, clinical onboarding begins, with nurses briefing the patient, scheduling diagnostics, and updating the treating doctor through the hospital’s systems. From here, care and monitoring continue in a loop of data collection and coordination.

When this workflow is carefully mapped, each step is clear, responsibilities are defined, and the information flow is reliable. Insurance clearance cannot occur after room allocation, because the order is already locked. Registration cannot skip details, because every downstream task depends on them. The mapping creates discipline and ensures that the process holds together.

It is only on this foundation that AI agents add real value. They can automatically verify insurance coverage, trigger alerts when financial clearance is delayed, schedule diagnostic tests in line with physician orders, or update records in real time. But if the underlying workflow is inconsistent for instance, if insurance checks sometimes happen before and sometimes after admission the agent merely accelerates the inconsistency. Instead of solving the problem, it makes it worse.

The same logic applies to outside hospitals. In employee onboarding, for instance, the workflow may run from offer acceptance to first-day orientation, but unless the processes are consistent—laptop provisioning, payroll activation, mandatory training—the onboarding experience becomes fragmented, and any attempt to automate simply multiplies the unevenness.

AI agents are not shortcuts. They are multipliers. They multiply the clarity of a well-mapped workflow and the strength of well-defined processes. But they also multiply the confusion where structure is missing. The real question for organisations is not what agents can do, but whether the workflows and processes in place are clear enough for them to succeed.

The relevance and importance of this becomes even more clear on a ready of the article in McKinsey. They argue that productivity gains do not come from redrawing the structure chart but from rethinking the process itself. Their framework of four levers eliminate, synchronize, streamline, and automate offers a practical way to make workflows more resilient and effective. The traditional disciplines of process mapping and standardisation, sometimes dismissed as dated, are in fact more critical than ever in the age of AI agents. To eliminate is to cut away what is redundant, whether duplicate reports, excessive meetings, or unnecessary checkpoints. To synchronize is to ensure that information flows across boundaries without delay, so that decisions are taken in context and in time. To streamline is to reduce clutter, focusing on what matters most to decision quality instead of drowning people in backward-looking commentary or irrelevant granularity. And to automate is to use digital tools to take over routine work, allowing human judgment and creativity to come to the fore.

Placed against the earlier examples, the relevance is obvious. In hospital admissions, eliminating unnecessary checkpoints, synchronising across clinical and financial functions, streamlining reporting to focus on patient readiness, and automating insurance checks would not only reduce errors but also accelerate outcomes. In employee onboarding, the same four levers would prevent duplication, improve hand-offs, and allow AI agents to truly enhance the experience rather than amplify confusion.

Seen this way, the emphasis on process is not old-fashioned bureaucracy but the very foundation of modern productivity. AI becomes a companion rather than a replacement. It multiplies whatever exists discipline or disorder and the responsibility lies with organisations to ensure that what exists is well designed. Only then can agents elevate performance, reduce wasted effort, and create sustainable value.

Industry Information update : Sector-wise Compendiums of Indian Standards

BIS Unveils 130 Sector-wise Compendiums of Indian Standards to Enhance Industry and Consumer Awareness

The Bureau of Indian Standards (BIS) has released a comprehensive collection of 130 sector-specific compendiums of Indian Standards, now accessible on the BIS portal.

Organized by industry sectors and product/service categories, these compendiums serve as consolidated reference guides for a wide range of stakeholders, including regulatory authorities, industry professionals, academic institutions, and consumer organizations.

Stakeholders can access the compendiums at
https://services.bis.gov.in/php/BIS_2.0/bisconnect/compendium_of_indian_standards_dept_wise

Please scan the QR code given below to download :

Source: https://services.bis.gov.in/php/BIS_2.0/bisconnect/compendium_of_indian_standards_dept_wise

Industry Information Update – BIS – Sector wise Calendar for Upcoming Webinars

Bureau of Indian Standards is organising Sector specific awareness programs

In order to spread the awareness among the concerned stakeholders, manufacturers, importers and common consumers BIS is organising ‘Interactive lecture series and Sector-wise webinar’ on the below mentioned topics.

Manufacturers including MSMEs are requested to attend the above webinars based on their respective business interests for a particular sector.

Participation in these webinars does not require any preregistration and can be joined conveniently and remotely through Computer / Laptops / Mobiles.

The link for joining these webinars are hosted well in advance on BIS Website: www.bis.gov.in

Source: https://www.bis.gov.in/

Industry Information Update – HOSPEX–QAI Quality Culture Award 2025

4th Edition of  HOSPEX Healthcare Expo cum Conferences will be held at Kochi, Kerala from Aug 22nd – 24th 2025. This is Kerala’s first B2B Medical Expo which will take place at KINFRA International Exhibition Centre, Kakanad, Kochi, Kerala

As a part of the Expo, to encourage, nurture the Culture of Practicing Quality in Small Hospitals, Hospex-QAI Quality Culture Award 2025 is designed this year.

About the Award:

The award is a joint initiative of HOSPEX India and QAI.

This award is a recognition of the Quality Focus that is built in Small Hospitals and the efforts taken by Small Hospitals to make Quality a Culture in their clinical settings.

For any Practice to become a Culture needs lot of commitment in any organisation. This award is created to motivate healthcare facilities to come forward and pitch their Quality Practices which have become a Culture in their settings.

About HOSPEX:       

Hospex is the initiative of Trithvam Integris, a company that specialises in managing Health and Medical Fair Events. Hospex is solely focused on digital health, healthcare and organising conferences for the medical industry by a group of doctors.

HOSPEX 2025 is the only Medical & Healthcare Exhibition in Kerala targeting Hospitals, Other Healthcare organisations, Medical Device Manufacturers, Pharmaceutical Manufacturers, Startups, Innovators in Health Tech and Med tech space.

The core focus of HOSPEX Healthcare Expo 2025 (Fourth Edition) is Medical Knowledge dissemination thereby hosts multitude of conferences focused on the futuristic trends in the medical industry. These conferences provide attendees with the opportunity to learn about new products and technologies, network with other professionals in the field, and stay up-to-date on the recent and futuristic developments in the industry

About QAI – Quality & Accreditation Institute

Quality and Accreditation Institute (QAI) is an International Accreditation Body that provides Accreditation/ Certification to Healthcare Organisations (Hospitals, Clinics, Dental centres, Eye Clinics, Imaging centres, IVF centres, Dialysis centres, Home Care, Stroke centres, Telehealth services, Hair Transplant Centres, Bone Marrow Transplant centres, Rehabilitation centres, Ambulatory care centres etc.).

QAI provides a platform to stakeholders including professionals and organisations, associated with Quality in any way, to share their wisdom and Knowledge in order to make healthcare services delivering better outcomes.

QAI is closely working with stakeholders including Government agencies to support accredited healthcare facilities in terms of empanelment and other benefits.

Target Segment:

Any healthcare facility such as Hospitals, Clinics, Dental centres, Eye Clinics, Imaging centres, IVF centres, Dialysis centres, Home Care providers, Stroke centres, Telehealth services, Hair Transplant Clinics, Bone Marrow Transplant centres, Rehabilitation centres, Ambulatory care centres etc.).

Wellness Centres offering AYUSH Services

Applicants can be from Private or Government settings.

Eligibility Criteria:

  • Applicant must have implemented a Quality Management System/ Patient Safety Program/ any Certification or Accreditation Program for a minimum period of last 3 years continuously
  • QAI accredited healthcare facility will be given preference
  • Applicant can be from any part of India

Application Form Content:

  • To be filled in the format given
  • General Information about the Healthcare facility
  • Specific information about Quality Practices/ Certifications / Accreditation (Evidences to be submitted to support any such claims)
  • 2 case studies/ examples to demonstrate improvement/ patient safety in last 3 years
  • Language for submission – English

Application Fee:

  • Rs. 1180/- (including 18% GST) for each application

    To be payable to HOSPEX India’s account as shared below:

    Tritvam Integris Pvt. Ltd.
    GST No: 32AAJCT2250M1ZA
    Tritvam Integris, Jyothi Trade Centre, Chettupuzha, PO,  Thrissur – 680 012

Application Submission Date:
Last date for submitting applications: 10 August 2025.

Completed Application including payment proof to be mailed to:

Ms. Chandni Rohila

Accreditation Officer
Quality & Accreditation Institute (QAI)
709, Wave Silver Tower, Sector 18, Noida-201301, India
Ph. No.: +911206664981
M: +91 8287841146
Email – chandni@qai.org.in

Terms and Conditions:

  • Only completed applications will be taken up for evaluation.
  • Jury will comprise of experienced professionals with healthcare operations, management, quality, clinical background
  • Only one application per location is acceptable.
  • Applicants can save the completed application and all evidences on a google drive folder and can share the folder access link to QAI through email to chandni@qai.org.in.
  • Applications submitted after the last date will not be entertained.
  • Jury will evaluate the applications and decide on the winners of the Award.
  • Shortlisted applicants may be called for virtual presentation, if needed.
  • Winners will be announced by 12 August 2025.
  • Winers will have to travel to Kochi (Cochin), to collect their Awards in an event to be held on 23 August 2025.
  • Organisers will not make any travel, stay arrangements and winners have to make their own arrangements.
  • Decision of the Jury shall be final and binding on all.

Source: https://hospex.in/

Industry Update – Guidance Document

Indian Council of Medical Research (ICMR) in coordination with Central Drugs Standard Control Organisation (CDSCO) has published a Guidance Document on Validation of Rapid Diagnostics for Pathogen Identification and Antimicrobial Susceptibility Testing (AST)

This document provides guidance for innovators and testing laboratories on validating diagnostics for pathogen identification and antimicrobial susceptibility testing.

It outlines a systematic framework to evaluate diagnostic performance, focusing on precision, accuracy, reproducibility, and the ability to detect target pathogens or their genetic materials (e.g., DNA, RNA, toxins, or antigens).

It also includes methods for antimicrobial susceptibility testing and prepares developers for the validation process by detailing evidence requirements and regulatory approval pathways.

Prepared by the AMR Coordination Unit of ICMR, this third draft incorporates expert feedback and inputs from the Central Drugs Standard Control Organization (CDSCO).

The document is designed to evolve with advancements in technology and methodologies, ensuring reliable diagnostics for clinical decision-making.

Source: https://www.icmr.gov.in/icmrobject/uploads/Guidelines/1736941384_guidancedocument_amrdiagnostics_revised.pdf

Industry update : NABL 112A & NABL 112B

National Accreditation Board for Testing and Calibration Laboratories (NABL) is an accreditation body that provides accreditation service to Conformity Assessment Bodies including medical testing laboratories. On December 18,2024, the following documents were issued by NABL.

1 – NABL 112ASpecific Criteria for Accreditation of Medical Laboratories

NABL 112 is a Specific Criteria for Accreditation of Medical Laboratories, prepared by a Technical Committee, which is aligned as per ISO 15189

NABL documents are updated at regular intervals to keep pace with the latest technical developments and to synchronize with the International Standards.

NABL has released NABL 112A which elaborates the requirements of International Standard ISO 15189:2022 as applicable to Indian setting. The document has been designed to make it user friendly for both NABL assessors and laboratories

This document specifies the criteria for the medical testing laboratories for obtaining NABL accreditation. Medical testing laboratory shall fulfill the requirements of this document in addition to the requirements of the ISO 15189:2022 – “Medical laboratories –Requirements for quality and competence”. This specific criteria document shall be used in conjunction with ISO 15189:2022..

2 – NABL 112 B – Guidance document for Medical Laboratories

NABL has issued 112B Document on 18th December 2024. This document shall provide guidance to medical testing laboratories for the following aspects:

– Operation of sample collection centres / facilities
– Sample format for preparing the scope of accreditation
– Lot verification
– Algorithm for Automated Selection and Reporting of Results
– Sample format for competency assessment
– Examples for the type of sample and their stability for Clinical Biochemistry parameters

Click the buttons given below to read the documents in detail.

Source: https://nabl-india.org/




Industry Update – Lab management Program

The Laboratory Management program targets middle to senior professionals in government institutions, private hospitals, and corporate laboratories.

It aims to equip participants with the knowledge and skills needed to manage and lead laboratories effectively while enabling them to pursue higher education.

Recognizing that 80% of patient care depends on diagnostic tests and analyses, the program focuses on developing competent leaders who can ensure laboratory quality, operational efficiency, and regulatory compliance, ultimately enhancing patient care and informed decision-making

Key Objectives of the program :

Leadership and Quality Excellence:
Develop leadership skills while ensuring compliance with international quality standards to enhance laboratory performance and patient care.

Technology and Innovation:
Leverage cutting-edge technologies, including Laboratory Information Systems (LIS) and artificial intelligence (AI), to modernize operations and improve diagnostic accuracy.

Financial and Risk Management:
Build expertise in financial planning and risk management to maintain sustainable and resilient laboratory operations.

Research and Clinical Competency:
Strengthen capabilities in research, clinical trials, and data management, fostering innovation and evidence-based decision-making.

Business Growth and Marketing:
Gain marketing and business development skills to expand laboratory services and succeed in competitive healthcare markets.

Who Should Attend ?

a. Laboratory Managers and Supervisors
b. Pathologists and Laboratory Technicians
c. Quality Assurance and Compliance Officers
d. Biotechnologists and Research
e. Scientists
f. Pharmaceutical and Clinical Trial
g. Professionals
h. Sales and Marketing Professionals in Diagnostics
i. Biomedical Engineers and Technologists
j. Corporate Laboratory Executives
k. Academicians and Trainers in Laboratory

Program Dates & Venue

The programme will start on Monday, March 24, 2025, and will conclude on Wednesday, March 26, 2025.

The programme will be held at IIHMR University, 1, Prabhu Dayal Marg, Sanganer Airport, Jaipur – 302 029.

The University campus provides a learning environment for the participants, who are welcome to use the library and recreational facilities at the campus

Program Fee :

The programme fee for Indian participants is Rs.30,000 plus GST (18% as applicable), and for international participants it is USD 355 plus GST (18% as applicable).

The programme fee covers tuition, background reading material, lodging, and boarding

Certificate of Participation:

A certificate of participation on completion of the programme will be issued by IIHMR University, Jaipur

Program Coordinators:

Kirti Agarwal
Manager-Strategic Planning and Partnership
IIHMR University, Jaipur

Puneet Sethi
COO and Co-Founder
BIO HUBB (A Unit Of Biopreseve Innovations LLP)

Registrations:

Please send your nominations/registrations to the following address

Programme Officer (Training)
IIHMR University
1, Prabhu Dayal Marg, Sanganer Airport,
Jaipur-302029, Rajasthan, India

Phone – +91-141-3924700
Email – training@iihmr.edu.in
Mobile – +91 9358790012

Source: https://iihmr.edu.in/

Industry Update – Establishment of the Global Accreditation Cooperation

The establishment of the Global Accreditation Cooperation (GLOBAC) marks a significant shift in the global accreditation landscape, merging the International Accreditation Forum (IAF) and the International Laboratory Accreditation Cooperation (ILAC) into a single entity.

This transition, aimed to be operational by January 2026, follows extensive discussions and agreements among IAF and ILAC members in 2024.

Key Developments

Formation of GLOBAC:

In 2019, IAF and ILAC members decided to create GLOBAC, which will take over their existing roles. The formal incorporation process began in New Zealand in October 2024 after the approval of GLOBAC’s Constitution and General Rules.

Mutual Recognition:

GLOBAC aims to enhance international trade by ensuring mutual recognition of accredited services across borders, thereby removing technical barriers. Until GLOBAC becomes operational, IAF and ILAC will continue their normal operations with existing recognition arrangements remaining valid

Transition Plan

Before Transition Date:

Until the Transition Date, IAF and ILAC will maintain their operations, and existing guidance for regulators will remain applicable. The IAF Multilateral Recognition Arrangement (IAF MLA) and ILAC Mutual Recognition Arrangement (ILAC MRA) will continue to function until GLOBAC takes over

After Transition Date:

Following the Transition Date, GLOBAC will assume all responsibilities of IAF and ILAC. Regulations referencing IAF MLA or ILAC MRA will gradually be updated to reflect GLOBAC’s framework. It is anticipated that the use of IAF MLA and ILAC MRA Marks will cease three years post-transition

Recommendations for Regulators:

Regulators are encouraged to collaborate with IAF and ILAC members to prepare for necessary changes in their documentation as GLOBAC becomes operational. This proactive approach will facilitate a smoother transition to the new accreditation framework

For further inquiries regarding this transition, stakeholders can contact the GLOBAC Executive Committee through its Secretary : secretary@globac.org

Industry Update – World Health Innovation Forum 2024

Kalam Institute of Health Technology (KIHT), Vizag is organising the 2nd edition of World Health Innovation Forum 2024 at Vizag from December 12th to 14th 2024.

Key Highlights of the Program

a. To Explore Innovation in Healthcare.
b. To Create Public Private Partnerships Platform.
c. To Support Policy-Making in Healthcare
d. To Impact Global Health.

To explore the transformative learning, unparalleled networking opportunities and collaborative initiatives please click the link https://www.whif.kiht.in/registration/ and register for the program.

For additional details on the program, please contact:
Email : whif@kiht.in
Phone: +91 8341622261

Source: https://www.whif.kiht.in/

Industry Update – MeDevIS (Medical Devices Information System) introduced by WHO

World Health Organization (WHO) has introduced an online platform called MeDevIS (Medical Devices Information System), the first global open access clearing house for information on medical devices. It is designed to support governments, regulators and users in their decision-making on selection, procurement and use of medical devices for diagnostics, testing and treatment of diseases and health conditions.

Here are the key insights from the news release about the MeDevIS platform from WHO :

Purpose and Scope: MeDevIS (Medical Devices Information System) is an online platform launched by WHO to provide global open access to information on medical devices. It aims to assist governments, regulators, and users in decision-making regarding the selection, procurement, and use of medical devices across various health conditions.

Coverage: The platform includes information on 2,301 types of medical devices used for a wide range of health issues, including reproductive health, noncommunicable diseases (e.g., cancer, cardiovascular diseases), infectious diseases (e.g., COVID-19), and more.

Complexity and Challenges: The increasing number and complexity of medical technologies make it challenging for healthcare practitioners and patients to navigate. MeDevIS aims to simplify access to reliable international information on medical devices, especially beneficial in resource-limited settings.

Functions and Features: Users can access detailed information about medical devices, including their types, suitable healthcare settings (e.g., community or specialized hospitals), scope of use, required infrastructure, and more. This replaces the need for separate searches across multiple publications with inconsistent naming conventions.

Nomenclature: MeDevIS incorporates two international naming systems for medical devices – the European Medical Device Nomenclature (EMDN) and the Global Medical Device Nomenclature (GMDN). These systems facilitate registration, procurement, regulatory approval, inventory management, and pricing of medical devices globally.

Impact and Benefits: The platform is expected to aid national policy-makers in developing procurement lists and contribute to universal health coverage goals. It can also support health insurance and reimbursement policies, benefiting patients globally.

Future Developments: WHO plans to continually improve MeDevIS by engaging stakeholders and expanding its coverage with additional medical technologies, including those needed in pandemic and emergency settings.

Overall, MeDevIS represents a significant initiative by WHO to enhance access to crucial medical technologies and devices worldwide, streamlining information dissemination and improving healthcare delivery.

Source:https://www.who.int/news/item/08-07-2024-medevis-platform-announced-to-boost-access-to-medical-technologies-and-devices